The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > BUSINESS
BUSINESS
- Yervoy Will Be First Choice for BRAF-Negative Malignant Melanoma: Skin Cancer Specialist
September 16, 2015
- Daiichi Sankyo Licenses Thrombus Dissolving Agent from US Firm
September 16, 2015
- MTPC Calls Off Japan PIII Program for Alzheimer’s Treatment
September 16, 2015
- Takeda Joins WIPO Consortium for Neglected Tropical Diseases
September 15, 2015
- Takeda Actos Settlement Expected to Become Effective
September 15, 2015
- Lilly Holds Partnering Event in Japan to Unearth Unique Seeds, R&D Chief Interested in 10-Plus Projects
September 14, 2015
- Takeda, Gencia Join Hands to Develop Novel Mitochondrial Therapeutics
September 14, 2015
- Eisai, Swiss Nonprofit to Jointly Develop Eumycetoma Treatment
September 14, 2015
- Novartis Paid 18.3 Billion Yen to Doctors, Medical Institutions in 2014
September 14, 2015
- Pfizer to Enjoy Monopoly in Asacol Generic Market until December
September 14, 2015
- Fluvoxamine Shows Significant Difference against Placebo for Pediatric Obsessive-Compulsive Disorder in PIII Study: Meiji Seika Pharma
September 14, 2015
- FDA Grants Priority Review Status to Multiple Myeloma Drug Ixazomib: Takeda
September 11, 2015
- Ethical Drug Sales Up 6.5% in July: Crecon Report
September 10, 2015
- MTPC, Biogen Partner Up on Imusera Successor
September 10, 2015
- Sanwa Kagaku, Ube to Codevelop Pruritus Treatment
September 10, 2015
- Clinical Study of JACE for Giant Pigmented Nevus Completed: J-TEC
September 9, 2015
- Sanofi Rolls Out Plaquenil, Lantus XR in Japan
September 8, 2015
- FDA Grants Breakthrough Therapy Designation to Hemophilia A Treatment ACE910: Chugai
September 7, 2015
- MSD Paid 13 Billion Yen to Doctors, Medical Institutions in 2014
September 3, 2015
- Merck Serono Japan Wants to Be Leader in Oncology, Fertility: President
September 3, 2015
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…